Showing results (111-120 of 163) with videos related to

Sort By:
Pageof 17
The Journal of Urology|March 3, 2018
Cystic Renal Cell Carcinoma: A Report on Outcomes of Surgery and Active Surveillance in Patients Retrospectively Identified on Pretreatment ImagingMahyar Kashan, Mazyar Ghanaat, Andreas M Hötker, et al.
The Journal of Urology|August 5, 2018
Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate CancerLucas W Dean, Melissa Assel, Daniel D Sjoberg, et al.
The Journal of Urology|October 10, 2018
Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate CancerYujiro Ito, Kazuma Udo, Emily A Vertosick, et al.
Prostate Cancer and Prostatic Diseases|February 26, 2020
Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancerSounak Gupta, Chad Vanderbilt, Wassim Abida, et al.
European Urology|August 14, 2022
The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract TumorsGeorge J Netto, Mahul B Amin, Daniel M Berney, et al.
European Urology|July 19, 2022
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular TumoursHolger Moch, Mahul B Amin, Daniel M Berney, et al.
European Urology|October 6, 2022
Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization ClassificationGeorge J Netto, Mahul B Amin, Eva M Compérat, et al.
European Urology|October 6, 2012
Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinomaA Ari Hakimi, Ying-Bei Chen, James Wren, et al.
The Journal of Pathology|May 7, 2011
Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinomaHikmat A Al-Ahmadie, Gopa Iyer, Manickam Janakiraman, et al.
Urology|July 30, 2020
RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell TumorsDouglas A Mata, Soo-Ryum Yang, Donna C Ferguson, et al.
Pageof 17